Results 171 to 180 of about 43,190 (248)
A rate‐and‐wait strategy for managing patients presenting to ED with AF, incorporating rate control and anticoagulation with next‐day community follow‐up has not increased hospital admission, re‐presentation, cardioversion or AE rates, compared to hospital‐based follow‐up.
Finn Brokenshire+6 more
wiley +1 more source
ABSTRACT It is unclear whether Japanese top‐selling drugs have meaningful added therapeutic benefits to justify their high sales. This question is relevant as Japan's healthcare costs are rising consistently, particularly due to increasing drug prices.
Hayase Hakariya+5 more
wiley +1 more source
Objective The purpose of this study was to investigate the effect of coronectomy on postoperative quality of life in older adults. Background Coronectomy is an alternative to complete surgical removal of a mandibular third molar that lies close to the inferior alveolar nerve.
Rashida N. Simons+3 more
wiley +1 more source
The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty [PDF]
Robert D. Russell+3 more
openalex +1 more source
ABSTRACT Splanchnic vein thrombosis (SVT) can be associated with liver cirrhosis or prothrombotic conditions, including myeloproliferative disorders, intra‐abdominal inflammation, solid cancers or surgery. While anticoagulation therapy improves outcomes in noncirrhotic patients and reduces all‐cause mortality in cirrhotic populations, its safety in ...
Rosa Talerico+8 more
wiley +1 more source
Antikoagulation bei Vorhofflimmern - Dabigatran, Rivaroxaban oder Apixaban - die Qual der Wahl? [PDF]
Armin Luik+2 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2371-2376, June 2025.
Ying Wang+7 more
wiley +1 more source
Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy
Abstract Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence in cancer‐related deaths. Although each patient and each tumor is wholly unique, the tipping point to incurable disease is common across all patients: the dual capacity for ...
Kenneth J. Pienta+2 more
wiley +1 more source
Rivaroxaban pour le traitement de l’embolie pulmonaire [PDF]
Nils Kucher
openalex +1 more source